Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 29330398

Management of important adverse events associated with inotuzumab ozogamicin: expert panel review.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Bone Marrow Transplant
Publication date
2018 Apr
First author
Kebriaei P

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Kebriaei P
      type
      Author
    2. name
      Cutler C
      type
      Author
    3. name
      de Lima M
      type
      Author
    4. name
      Giralt S
      type
      Author
    5. name
      Lee SJ
      type
      Author
    6. name
      Marks D
      type
      Author
    7. name
      Merchant A
      type
      Author
    8. name
      Stock W
      type
      Author
    9. name
      van Besien K
      type
      Author
    10. name
      Stelljes M
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Kebriaei P
      type
      Author
    2. name
      Cutler C
      type
      Author
    3. name
      de Lima M
      type
      Author
    4. name
      Giralt S
      type
      Author
    5. name
      Lee SJ
      type
      Author
    6. name
      Marks D
      type
      Author
    7. name
      Merchant A
      type
      Author
    8. name
      Stock W
      type
      Author
    9. name
      van Besien K
      type
      Author
    10. name
      Stelljes M
      type
      Author
    bibliography ids
    1. nci-bib-5fb562d79e00c33b4b397693
    book metadata
    content sha256
    4e4738fe6a51f62648c053153d61aa9a5a61b2e808e63dc35c44f4ce25dd7742
    document type
    citation
    dois
    1. 10.1038/s41409-017-0019-y
    electronic publication date
    display
    2018 Jan 12
    precision
    day
    year
    2018
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:29330398
    immutable id
    pubmed:29330398@4e4738fe6a51f62648c053153d61aa9a5a61b2e808e63dc35c44f4ce25dd7742
    journal
    abbreviation
    Bone Marrow Transplant
    issn electronic
    1476-5365
    issn print
    0268-3369
    issue
    4
    name
    Bone marrow transplantation
    nlm unique id
    8702459
    pages
    449-456
    volume
    53
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      29330398
      provenance
      batch id
      ec9444d0f4cade22eb9f
      provider
      NCBI PubMed ESummary
      record sha256
      dadaab6f48d1d7416c9a7cdabcbc2d133292f8f33a76a4e77ae4ac68e815c99d
      response sha256
      6eef0d8cc09b77e73af656f6390cc734befb84fbc4c229b886e81e5d95bece31
      retrieved at
      2026-09-09T23:47:30.975610+00:00
      publication date
      display
      2018 Apr
      precision
      month
      year
      2018
      publication types
      1. Journal Article
      2. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/29330398/
      title
      Management of important adverse events associated with inotuzumab ozogamicin: expert panel review.

      Preserved source evidence · Not medical advice